Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways

Yan,Hong; Che,Xiaoxia; Lv,Qingtao; Zhang,Lili; Dongol,Samina; Wang,Yilin; Sun,Hengzi; Jiang,Jie

doi:10.3892/ol.2017.6092

Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways

Authors:
- Hong Yan
- Xiaoxia Che
- Qingtao Lv
- Lili Zhang
- Samina Dongol
- Yilin Wang
- Hengzi Sun
- Jie Jiang
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Shandong University Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Pharmaceutical Chemistry, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250013, P.R. China, Department of Ultrasonography, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250355, P.R. China
Published online on: April 25, 2017 https://doi.org/10.3892/ol.2017.6092
Pages: 4806-4812
Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Grifolin, a secondary metabolic product isolated from the mushroom Albatrellus confluence, has been demonstrated to possess antitumor activities in a variety of malignant cells. However, the signaling pathways and the molecular mechanisms underlying the anticancer effects of the agent in human ovarian cancer remain to be elucidated. The aim of the present study was to examine the effect of grifolin treatment on the human ovarian cancer cell line, A2780. MTT and flow cytometry analysis were used to analyze the viability of A2780 cells following treatment with grifolin. Western blotting was used analyze the expression of apoptosis‑associated and cell cycle arrest‑associated proteins. The results of MTT assays and flow cytometry analysis revealed that grifolin suppressed cell viability, induced apoptosis and triggered cell cycle arrest. Western blotting revealed that grifolin treatment resulted in inactivation of protein kinase B (Akt) and extracellular signal‑related kinase 1/2 (ERK1/2), accompanied by upregulation of Bcl‑2 associated X, apoptosis regulator, cleaved‑caspase‑3 and cleaved‑poly (ADP‑ribose) polymerase, and downregulation of B cell lymphoma‑2, cyclin dependent kinase 4 and cyclinD1. The results of the present study indicated that grifolin had significant anti-cancer effects on the human ovarian cancer A2780 cells, which occurred via the Akt and ERK1/2 signaling pathways to at least a certain extent. These results demonstrate the therapeutic potential of grifolin as a treatment for ovarian cancer.

View Figures

View References

1	Gloss BS and Samimi G: Epigenetic biomarkers in epithelial ovarian cancer. Cancer Lett. 342:257–263. 2014. View Article : Google Scholar : PubMed/NCBI
2	Chen C, Chang YC, Lan MS and Breslin M: Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways. Int J Oncol. 42:1113–1119. 2013.PubMed/NCBI
3	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
4	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
5	Jayson GC, Kohn EC, Kitchener HC and Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014. View Article : Google Scholar : PubMed/NCBI
6	Luo X, Yu X, Liu S, Deng Q, Liu X, Peng S, Li H, Liu J and Cao Y: The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (review). Oncol Rep. 34:547–554. 2015.PubMed/NCBI
7	Ye M, Luo X, Li L, Shi Y, Tan M, Weng X, Li W, Liu J and Cao Y: Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett. 258:199–207. 2007. View Article : Google Scholar : PubMed/NCBI
8	Jin S, Pang RP, Shen JN, Huang G, Wang J and Zhou JG: Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis. 12:1317–1326. 2007. View Article : Google Scholar : PubMed/NCBI
9	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
10	Hilakivi-Clarke L, Wang C, Kalil M, Riggins R and Pestell RG: Nutritional modulation of the cell cycle and breast cancer. Endocr Relat Cancer. 11:603–622. 2004. View Article : Google Scholar : PubMed/NCBI
11	Hall M and Peters G: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res. 68:67–108. 1996. View Article : Google Scholar : PubMed/NCBI
12	Kaukoniemi KM, Rauhala HE, Scaravilli M, Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL and Visakorpi T: Epigenetically altered miR-193b targets cyclin D1 in prostate cancer. Cancer Med. 4:1417–1425. 2015. View Article : Google Scholar : PubMed/NCBI
13	Denault JB and Boatright K: Apoptosis in biochemistry and structural biology. 3–8 February 2004, Keystone, CO, USA. IDrugs. 7:315–317. 2004.PubMed/NCBI
14	Gupta S, Kass GE, Szegezdi E and Joseph B: The mitochondrial death pathway: A promising therapeutic target in diseases. J Cell Mol Med. 13:1004–1033. 2009. View Article : Google Scholar : PubMed/NCBI
15	Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, Mehal WZ, Inayat I and Flavell RA: Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis. Science. 311:847–851. 2006. View Article : Google Scholar : PubMed/NCBI
16	Langelier MF and Pascal JM: PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis. Curr Opin Struct Biol. 23:134–143. 2013. View Article : Google Scholar : PubMed/NCBI
17	Sukhanova MV, Khodyreva SN and Lavrik OI: Influence of poly(ADP-ribose) polymerase-1 and its apoptotic 24-kD fragment on repair of DNA duplexes in bovine testis nuclear extract. Biochemistry (Mosc). 71:736–748. 2006. View Article : Google Scholar : PubMed/NCBI
18	Monian P and Jiang X: Clearing the final hurdles to mitochondrial apoptosis: Regulation post cytochrome C release. Exp Oncol. 34:185–191. 2012.PubMed/NCBI
19	Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
20	Cotter TG: Apoptosis and cancer: The genesis of a research field. Nat Rev Cancer. 9:501–507. 2009. View Article : Google Scholar : PubMed/NCBI
21	Antonsson B: Bax and other pro-apoptotic Bcl-2 family ‘killer-proteins’ and their victim the mitochondrion. Cell Tissue Res. 306:347–361. 2001. View Article : Google Scholar : PubMed/NCBI
22	Blanco-Aparicio C, Renner O, Leal JF and Carnero A: PTEN, more than the AKT pathway. Carcinogenesis. 28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
23	Fingar DC, Salama S, Tsou C, Harlow E and Blenis J: Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/elF4E. Genes Dev. 16:1472–1487. 2002. View Article : Google Scholar : PubMed/NCBI
24	Serrano ML, Sánchez-Gómez M, Bravo MM, Yakar S and LeRoith D: Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines. Horm Metab Res. 40:661–667. 2008. View Article : Google Scholar : PubMed/NCBI
25	Diab S, Kumarasiri M, Yu M, Teo T, Proud C, Milne R and Wang S: MAP kinase-interacting kinases-emerging targets against cancer. Chem Biol. 21:441–452. 2014. View Article : Google Scholar : PubMed/NCBI